Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

IGSF11 and VISTA: a pair of promising immune checkpoints in tumor immunotherapy
Xiyang Tang, Yanlu Xiong, Xian-Gui Shi, et al.
Biomarker Research (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 11

Showing 11 citing articles:

Eliminating a barrier: Aiming at VISTA, reversing MDSC-mediated T cell suppression in the tumor microenvironment
Yayuan Deng, Mengjia Shi, Yi Lin, et al.
Heliyon (2024) Vol. 10, Iss. 17, pp. e37060-e37060
Open Access | Times Cited: 37
Co-expression of immune checkpoints in glioblastoma revealed by single-nucleus RNA sequencing and spatial transcriptomics
Dingyi Yuan, Wenting Chen, Shasha Jin, et al.
Computational and Structural Biotechnology Journal (2024) Vol. 23, pp. 1534-1546
Open Access | Times Cited: 6
The VISTA/VSIG3/PSGL-1 axis: crosstalk between immune effector cells and cancer cells in invasive ductal breast carcinoma
Mateusz Olbromski, Monika Mrozowska, Aleksandra Piotrowska, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 8
Open Access | Times Cited: 4
Unraveling Tumor-to-Tumor Metastasis: Insights into Pathogenesis, Diagnostic Challenges, and Treatment Modalities
W Mei, Dongdong Zhang
Biologics (2025) Vol. Volume 19, pp. 43-58
Open Access
Different expression patterns of VISTA concurrent with PD-1, Tim-3, and TIGIT on T cell subsets in peripheral blood and bone marrow from patients with multiple myeloma
Shuxin Huang, Yujie Zhao, Pengjun Liao, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 12
Targeted drug-loaded peptides induce tumor cell apoptosis and immunomodulation to increase antitumor efficacy
Hongjie Li, Peirong Zhang, Xiaomeng Yuan, et al.
Biomaterials Advances (2024) Vol. 160, pp. 213852-213852
Closed Access | Times Cited: 2
Predictive value of co-expression patterns of immune checkpoint molecules for clinical outcomes of hematological malignancies.
Cunte Chen, Yangqiu Li
PubMed (2023) Vol. 35, Iss. 3, pp. 245-251
Closed Access | Times Cited: 6
H-VISTA Immunohistochemistry Score Is Associated with Advanced Stages in Cutaneous and Ocular Melanoma
Andreea Cătălina Tinca, Andreea Raluca Szöke, Bianca Andreea Lazar, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4335-4335
Open Access | Times Cited: 1
Promises and challenges for targeting the immunological players in the tumor micro-environment – Critical determinants for NP-based therapy
P.K. Suresh, Arindam Banerjee, Preeti Singh
OpenNano (2023) Vol. 10, pp. 100134-100134
Open Access | Times Cited: 2
Uncovering the regulatory roles of miR-4319 in tumour progression
Zhi Xiong Chong
Human Gene (2024) Vol. 41, pp. 201312-201312
Closed Access
VSIG-3/IGSF11 silencing in A2058 melanoma cells simultaneously suppresses melanoma progression and induces anti-tumoral cytokine profile in human T cells: In silico and in vitro study
Najibeh Shekari, Dariush Shanehbandi, Elham Baghbani, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access
Page 1

Scroll to top